Differential clinical significance of α(v)β3 expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes

International Journal of Cancer

Volumn 86, Issue 3, 2000, Pages 153-159

  Kageshita, Toshiro ^a   Hamby, Carl V ^b   Hikai, Shunji ^a   Kimura, Toru ^a   Ono, Tomomichi ^a   Ferrone, Soldano ^c  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; TUMOR ANTIGEN; TUMOR PROTEIN; VITRONECTIN RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CARCINOGENESIS; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; CELL CULTURE; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LENTIGO; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SKIN TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LENTIGO; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, VITRONECTIN; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0034688936     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000320)89:2<153::aid-ijc9>3.0.co;2-1     Document Type: Article

References (25)

1. 3 subunit with tumor progression. Cancer Res., 50, 6757-6764 (1990).
2. 3. Cell, 85, 683-693 (1996).
3. CARREL, S., DORÉ, J.-F., RUITER, D.J., PRADE, M., LEJEUNE, F.J., KLEEBERG, U.R., RUMKE, P. and BROCKER, E.B., The EORTC Melanoma Group Exchange Program: evaluation of a multicenter monoclonal antibody study. Int. J. Cancer, 48, 836-847 (1991).
4. CASCINELLI, N., ZURRIDA, S., GALIMBERTI, V., BARTOLI, C., BUFALINO, R., DEL PRATO, I., MASCHERONI, L., TESTORI, A. and CLEMENTE, C., Acral lentiginous melanoma. A histological type without prognostic significance. J. Dermatol. surg. Oncol., 20, 817-822 (1994).
5. 3 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice [published erratum appears in Int. J. Cancer, 62, 365]. Int. J. Cancer, 61, 491-496 (1995).
6. 3 vitronectin-receptor expression in melanocytic tumor progression. Histopathology, 24, 249-256 (1994).
7. v gene expression in human melanoma tumorigenicity. J. clin. Invest., 89, 2018-2022 (1992).
8. GIACOMINI, P., NG, A.K., KANTOR, R.R., NATALI, P.G. and FERRONE, S., Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen. Cancer Res., 43, 3586-3590 (1983).
9. 3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Amer. J. Pathol., 153, 1435-1442 (1998).
10. KAGESHITA, T., KURIYA, N., ONO, T., HORIKOSHI, T., TAKAHASHI, M., WONG, G.Y. and FERRONE, S., Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Cancer Res., 53, 2830-2833 (1993a).
11. KAGESHITA, T., YOSHII, A., KIMURA, T., KURIYA, N., ONO, T., TSUJISAKI, M., IMAI, K. and FERRONE, S., Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res., 53, 4927-4932 (1993b).
12. MARSHALL, J.F., NESBITT, S.A., HELFRICH, M.H., HORTON, M.A., POLAKOVA, K. and HART, I.R., Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int. J. Cancer, 49, 924-931 (1991).
13. MATSUI, M., TEMPONI, M. AND. FERRONE, S., Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon. J. Immunol., 139, 2088-2095 (1987).
14. MCGREGOR, B.C., MCGREGOR, J.L., WEISS, L.M., WOOD, G.S., HU, C.H., BOUDERCHE, H. and WARNKE, R.A., Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Amer. J. clin. Pathol., 92, 495-499 (1989).
15. MEREDITH, J.E., JR. and SCHWARTZ, M.A., Integrins, adhesion and apoptosis. Trends Cell Bio., 7, 146-150 (1997).
16. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. nat. Acad Sci. (Wash.), 91, 8856-8860 (1994).
17. NAGAKURA, S., NAKAKUMA, H., HORIKAWA, K., HIDAKA, M., KAGIMOTO, T., KAWAKITA, M., TOMITA, M. and TAKATSUKI, K., Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients. Amer. J. Hematol., 43, 14-18 (1993).
18. 3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res., 57, 1554-1560 (1997).
19. NATALI, P.G., NICOTRA, M.R., CAVALIERE, R., BIGOTTI, A., ROMANO, G., TEMPONI, M. and FERRONE, S., Differential expression of intercellular adhesion molecule-1 in primary and metastatic melanoma lesions. Cancer Res., 50, 1271-1278 (1990).
20. 3 to adhere to lymph node vitronectin. J. clin. Invest., 90, 1406-1413 (1992).
21. SI, Z. and HERSEY, P., Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and selectins on melanoma cells. Pathology, 26, 6-15 (1994).
22. TEMPONI, M., KAGESHITA, T., PEROSA, F., ONO, T., OKADA, H. and FERRONE, S., Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma, 8, 85-95 (1989).
23. TEN BERGE, P.J.M., DANEN, E.H.J., VAN MUIJEN, G.N.P., JAGER, J.J. and RUITER, D.J., Integrin expression in uveal melanoma differs from cutaneous melanoma. Invest. Ophthalmol. vis. Sci., 34, 3635-3640 (1993).
24. VUORI, K. and RUOSLAHTI, E., Association of insulin receptor substrate-1 with integrins. Science, 266, 1576-1578 (1994).
25. WICK, M.R., Malignant melanoma of the skin. In: I.D. Fleming, J.S. Cooper, D.E. Henson, R.V.P. Hutter, B.J. Kennedy, G.P. Murphy, B. O'Sullivan, L.H. Sobin and J.W. Yarbro (eds.), AJCC cancer staging manual, pp. 163-167, Lippincott-Raven, Philadelphia (1997).